Records containing: SARS-CoV-2
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2025-03-30A Phase 1/2, Randomized Double-blind Placebo-Controlled Trial to Test the Safety and Antiviral Activity of ACE2 Chewing Gum on SARS-CoV-2 Viral Load (COVID 19)
-
CLINICAL_TRIALS study record update · 2025-03-26Phase I/II, Open-Label Dose-Finding Trial of High-Dose mRNA-1273 Booster for Lung Transplant Recipients
-
CLINICAL_TRIALS study record update · 2025-03-20Virus-induced Immunosuppression Via Infection of Hematopoietic Progenitors
-
CLINICAL_TRIALS study record update · 2025-03-10PROTECT: A Randomized Study With Hydroxychloroquine Versus Observational Support for Prevention or Early Phase Treatment of Coronavirus Disease (COVID-19)
-
CLINICAL_TRIALS study record update · 2025-03-07A Phase 1, Randomized, Double-Blind, Placebo-Controlled, Dose Escalation Study to Evaluate the Safety, Pharmacokinetics, and Immunogenicity of ADM03820 in Adults
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2025-02-28A Phase 2/3 Study to Evaluate the Immunogenicity and Safety of mRNA Vaccine Boosters for SARS-CoV-2 Variants
-
CLINICAL_TRIALS study record update · 2025-02-21A Phase 1, Open-label, Safety and Immunogenicity Study of a Booster Dose of the Investigational CV0501 mRNA COVID-19 Vaccine in Adults at Least 18 Years Old
-
CLINICAL_TRIALS study record update · 2025-02-14A Prospective Multicenter Study Conducted to Evaluate the Performance of the LumiraDX SARS-CoV-2 Ag Ultra and LumiraDX SARS-CoV-2 & Flu A/B Tests at Point of Care Sites
-
CLINICAL_TRIALS study record update · 2025-02-11Identification of Biomarkers for Post-COVID Conditions
-
CLINICAL_TRIALS study record update · 2025-01-27Addressing Post-COVID-19 Musculoskeletal Symptoms Through Telemedicine
-
CLINICAL_TRIALS study record update · 2025-01-21An Observational Study to Assess the Real-world Effectiveness of EVUSHELD™ (Tixagevimab/Cilgavimab) as Pre-exposure Prophylaxis Against COVID-19 Among Immunocompromised Patients in Israel
-
CLINICAL_TRIALS study record update · 2024-12-30A Phase 2a, Open Label Extension Study to Assess the Safety and Long-Term Immunogenicity of ARCT-021
-
CLINICAL_TRIALS study record update · 2024-12-19Post-marketing Safety of Elasomeran/Davesomeran and Andusomeran Vaccines in the United States
-
CLINICAL_TRIALS study record update · 2024-12-10Phase 1, Open-Label, Dose-Escalation Study to Evaluate the Safety and Immunogenicity of VXCO-100 in Adults in the Republic of South Africa
-
CLINICAL_TRIALS study record update · 2024-12-10A Phase 1, Open-Label, Dose-Escalation Study to Evaluate the Safety and Immunogenicity of VXCO-100 in Healthy Adults in the United States
-
CLINICAL_TRIALS study record update · 2024-12-09A Study to Evaluate the Efficacy and Safety of VYD222 for Prevention of COVID-19 (CANOPY)
-
CLINICAL_TRIALS study record update · 2024-11-13Assessment of Covid-19 Infection Rates in Healthcare Workers Using a Desynchronization Strategy
-
CLINICAL_TRIALS study record update · 2024-10-26CORVax12 - a Phase I Trial of SARS-CoV-2 Spike (S) Protein Plasmid DNA Vaccine (CORVax) +/- pIL-12 (Tavokinogene Telseplasmid) in Healthy Volunteers, With Immunodynamic Biomarker Monitoring of Coordinated Cellular/Humoral Response
-
CLINICAL_TRIALS study record update · 2024-09-25Extended Remdesivir Infusion Combined With Nirmatrelvir/Ritonavir for Persistent SARS-CoV-2 Infection in Immunocompromised Patients
-
CLINICAL_TRIALS study record update · 2024-09-24A Randomised, Double-Blind, Dose-Escalation Phase I Study in Healthy Adults to Assess the Safety, Tolerability and Immunogenicity of Glycovax-002, a Novel Vaccine Candidate Against COVID-19
-
CLINICAL_TRIALS study record update · 2024-09-19A Phase II/III Partially Double-Blinded, Randomised, Multinational, Active-Controlled Study in Both Previously Vaccinated and Unvaccinated Adults to Determine the Safety and Immunogenicity of AZD2816, a Vaccine for the Prevention of COVID-19 Caused by Variant Strains of SARS-CoV-2
-
CLINICAL_TRIALS study record update · 2024-08-14Use of Behavioral Economics in Repeat SARS-CoV-2 (COVID-19) Antibody Testing in Disadvantaged Communities
-
CLINICAL_TRIALS study record update · 2024-08-12SJTRC-St. Jude Tracking of Viral and Host Factors Associated With COVID-19: A Prospective Adaptive Cohort Study
-
CLINICAL_TRIALS study record update · 2024-08-12A Phase 1, Open-label, Safety, Reactogenicity, and Immunogenicity Trial of the CV2CoV mRNA Vaccine Against SARS CoV 2 in Seropositive Adult Participants
-
CLINICAL_TRIALS study record update · 2024-08-09A Phase 2/3, Randomized, Observer-blind, Active-controlled, Multicenter Study to Evaluate the Immunogenicity and Safety of Omicron Variant Vaccines in Comparison With mRNA-1273 (Prototype) Booster Vaccine